Prostate Cancer Clinical Trials in Houston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Recruiting
  • Prostate Cancer
  • talazoparib plus enzalutamide
  • Placebo plus enzalutamide
  • Tucson, Arizona
  • +122 more
2021-10-14
Oct 14, 2021
P
Recruiting
  • Non-small Cell Lung Cancer
  • +9 more
  • Little Rock, Arkansas
  • +50 more
2021-10-14
Oct 14, 2021
P
Active, not recruiting
  • Hormone Sensitive Prostate Cancer
  • +2 more
  • Birmingham, Alabama
  • +256 more
2021-10-12
Oct 12, 2021
E
Recruiting
  • Locally Advanced Solid Tumor
  • +16 more
  • Birmingham, Alabama
  • +26 more
2021-10-13
Oct 13, 2021
U
Recruiting
  • Prostate Cancer
  • Standard of Care IMRT (Photon)
  • +3 more
  • Birmingham, Alabama
  • +54 more
2021-10-11
Oct 11, 2021
J
Active, not recruiting
  • Prostate Cancer
  • Prostatic Neoplasm
  • abiraterone acetate in combination with prednisone
  • Homewood, Alabama
  • +44 more
2021-10-07
Oct 7, 2021
L
Completed
  • Prostate Cancer
  • +4 more
  • NY-ESO-1 Plasmid DNA Cancer Vaccine
  • New York, New York
  • +1 more
2021-09-15
Sep 15, 2021
C
E
Active, not recruiting
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
2021-09-30
Sep 30, 2021
M
Recruiting
  • Prostate Cancer
  • Docetaxel 75 mg/m2
  • +2 more
  • Gilbert, Arizona
  • +48 more
2021-09-21
Sep 21, 2021
M
Active, not recruiting
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-09-23
Sep 23, 2021
M
Not yet recruiting
  • Prostate Cancer
  • restriction spectrum imaging (RSI)
  • Houston, Texas
    M D Anderson Cancer Center
2021-09-21
Sep 21, 2021
A
Recruiting
  • Prostate Cancer
  • Anchorage, Alaska
  • +121 more
2021-09-19
Sep 19, 2021
M
Active, not recruiting
  • Prostate Cancer
  • LHRH Agonist
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-09-22
Sep 22, 2021
D
Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
2021-09-21
Sep 21, 2021
C
Active, not recruiting
  • Prostate Cancer
  • Aglatimagene besadenovec + valacyclovir
  • Placebo + valacyclovir
  • Gilbert, Arizona
  • +72 more
2021-09-16
Sep 16, 2021
M
Not yet recruiting
  • Prostate Cancer
  • Prostate Nodule
  • 18F-fluciclovine
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
2021-09-03
Sep 3, 2021
B
Active, not recruiting
  • Prostate Cancer
  • rhPSMA-7.3 (18F) Injection
  • Birmingham, Alabama
  • +33 more
2021-09-08
Sep 8, 2021
B
Active, not recruiting
  • Prostate Cancer
  • rhPSMA-7.3 (18F) Injection
  • Birmingham, Alabama
  • +27 more
2021-09-08
Sep 8, 2021
E
Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
2021-09-02
Sep 2, 2021
K
Recruiting
  • HER2-positive Breast Cancer
  • +43 more
  • Sarasota, Florida
  • +9 more
2021-08-31
Aug 31, 2021
U
Recruiting
  • Oncology
  • +37 more
  • Radiation therapy
  • Houston, Texas
  • +7 more
2021-08-23
Aug 23, 2021
A
Recruiting
  • Ovarian Cancer
  • +3 more
  • Duarte, California
  • +34 more
2021-08-25
Aug 25, 2021
P
Recruiting
  • Prostate Cancer
  • Standard of Care
  • Birmingham, Alabama
  • +103 more
2021-08-25
Aug 25, 2021